ClinicalTrials.Veeva

Menu

The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

S

Showa Inan General Hospital

Status

Completed

Conditions

Gastric Cancer
Helicobacter Pylori
Eradication
Medical Care Cost

Study type

Observational

Funder types

Other

Identifiers

NCT00596401
sihp20076

Details and patient eligibility

About

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

Enrollment

3,000 patients

Sex

All

Ages

19 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • People who live in Iijima town at their age of 19 to 69 years

Trial design

3,000 participants in 3 patient groups

1
Description:
HP eradication group
2
Description:
No eradication group
3
Description:
No Hp group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems